Correspondence to: Dr Peter Henningsen, Department of Psychosomatic Medicine, University Hospital, Thibautstr 2, 69115 Heidelberg, Germany; peter_henningsen{at}med.uni-heidelberg.de Objective: To ...
2 Department of Neurology, IRYCIS, Hospital Ramon y Cajal, Madrid, Spain 3 Department of Neurology, Hospital Fundacion Alcorcon, Madrid, Spain 4 Department of Neurology, Hospital Puerta de Hierro, ...
1 Department of Clinical Neurology, The Royal Hallamshire Hospital, Sheffield, UK 2 Department of Gastroenterology, The Royal Hallamshire Hospital Correspondence to: Dr M Hadjivassiliou, Department of ...
Correspondence to: Professor J Wardlaw, Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; jmw{at}skull.dcn.ed.ac.uk Objectives: To determine the ...
Department of Clinical Neurosciences, University of Cambridge Clinical School, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK N Robertson, Helen Durham Neuro-inflammatory Centre, Department of ...
Faculty of Medicine MS/MRI Research Group, University of British Columbia, Vancouver, Canada Helen Tremlett, PhD, Department of Medicine (Neurology), rm S178, 2211 Wesbrook Mall, University of British ...
Cerebral lesions may alter the capability of bilingual subjects to separate their languages and use each language in appropriate contexts. Patients who show pathological mixing intermingle different ...
Objectives To evaluate the validity, reliability, responsiveness and meaningful change threshold of the Inclusion Body Myositis (IBM) Functional Rating Scale (FRS). Methods Data from a large 20-month ...
Movement disorders arise from the complex interplay of multiple changes to neural circuits. Successful treatments for these disorders could interact with these complex changes in myriad ways, and as a ...
Background Depression is often cited as a major modifiable risk factor for dementia, though the relative contributions of a true causal relationship, reverse causality and confounding factors remain ...
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience
Background We report our experience of patients with generalised myasthenia gravis (gMG) treated with efgartigimod, an neonatal Fc receptor antagonist, under the Early Access to Medicine Scheme (EAMS) ...
The brain is in a constant state of dynamic change, for example switching between cognitive and behavioural tasks, and between wakefulness and sleep. The brains of people with epilepsy have additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback